Radioiodine‐Mediated Transition Metal Valence Conversion for Enhanced Chemodynamic Therapy
Advanced Functional Materials · 2024-08 · 34 (34)
DOI: 10.1002/adfm.202400791 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 07.05.2024. Verfasst von Tao Wang und 11 weiteren Autor:innen. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Chemodynamic therapy (CDT) presents promise as a cancer treatment method, but its efficacy faces challenges due to the inefficient Fenton catalytic reaction, where the transition metals' conversion from high to low valence states acts as the rate‐limiting step. Here, a strategy employing radioiodine is introduced to facilitate the valence conversion of transition metals for CDT enhancement. Iron‐based metal‐organic framework (MOF) nanoparticles (NPs) are synthesized labeled with radioiodine‐125 ( 125 I), referred to as 125 I‐MIL‐88B(Fe) NPs. These NPs possess a porous structure capable of concentrating and catalyzing H 2 O 2 to generate highly toxic hydroxyl radicals (·OH). Furthermore, 125 I can continuously produce hydrated electrons (e aq − ) in aqueous environments, promoting the conversion of Fe 3+ /Fe 2+ to boost ·OH production. In vitro and in vivo experiments validate the enhanced CDT effect on pancreatic cancer, driven by the reactive oxygen species (ROS)/mitogen‐activated protein kinase (MAPK)/p53 pathway‐mediated cell apoptosis. The radioiodine‐mediated electron‐supplying strategy not only amplifies the effectiveness of CDT but also unlocks new potential applications for radionuclides.
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Wang, T., Wang, C., Wang, Y., Zhang, X., Cai, X., Guo, Z., Meng, X., Jiang, X., Wu, Y., Cao, Y., Zuo, C., & Bu, W. (2024). Radioiodine‐Mediated Transition Metal Valence Conversion for Enhanced Chemodynamic Therapy. Advanced Functional Materials, 34(34). https://doi.org/10.1002/adfm.202400791
Vancouver
Wang T, Wang C, Wang Y, Zhang X, Cai X, Guo Z, et al. Radioiodine‐Mediated Transition Metal Valence Conversion for Enhanced Chemodynamic Therapy. Advanced Functional Materials. 2024;34(34). doi:10.1002/adfm.202400791
BibTeX
@article{Wang2024,
author = {Wang, Tao and Wang, Chaochao and Wang, Ya and Zhang, Xuelian and Cai, Xuechao and Guo, Zhongqiu and Meng, Xianfu and Jiang, Xingwu and Wu, Yelin and Cao, Yi and Zuo, Changjing and Bu, Wenbo},
title = {Radioiodine‐Mediated Transition Metal Valence Conversion for Enhanced Chemodynamic Therapy},
journal = {Advanced Functional Materials},
year = {2024},
volume = {34},
number = {34},
doi = {10.1002/adfm.202400791}
}
EUVIMED